Ginkgo Bioworks Holdings (DNABW) Interest & Investment Income (2020 - 2021)
Ginkgo Bioworks Holdings (DNABW) reported Interest & Investment Income of $496000.0 for Q4 2021, up 116.63% on a YoY basis from $228964.4 in Q4 2020, and up 309.92% quarter-over-quarter from $121000.0 in Q3 2021.
Ginkgo Bioworks Holdings (DNABW) Interest & Investment Income (2020 - 2021) Analysis & Trends
Ginkgo Bioworks Holdings has reported Interest & Investment Income for 2 years, with the latest figure at $496000.0 in Q4 2021.
- For the quarter ending Q4 2021, Interest & Investment Income rose 116.63% year-over-year to $496000.0; the trailing twelve-month figure through Dec 2021 stood at $952000.0 (changed N/A YoY), and the FY2025 full-year result was $22.6 million, down 41.43% from the prior year.
- Interest & Investment Income for Q4 2021 stood at $496000.0, up from $121000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $3.3 million in Q3 2020, with the low at -$3.0 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Ginkgo Bioworks Holdings | - | - | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 496,000.00 |
| Sep 30, 2021 | 121,000.00 |
| Dec 31, 2020 | -2.98 Mn |
| Sep 30, 2020 | 3.32 Mn |